• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Astragalus injection as an adjuvant treatment for colorectal cancer: a meta-analysis

    2020-01-15 01:57:02JiaWangZhuYangFengxiLongLiLuoJinlinWuTingYuDongxinTang
    Traditional Medicine Research 2020年1期

    Jia Wang, Zhu Yang, Fengxi Long, Li Luo, Jinlin Wu, Ting Yu, Dongxin Tang

    Astragalus injection as an adjuvant treatment for colorectal cancer: a meta-analysis

    Jia Wang1, 3, Zhu Yang1, 3, Fengxi Long1, 3, Li Luo3, 4, Jinlin Wu1, 3, Ting Yu1, 3, Dongxin Tang2, 3*

    1Guizhou University of Traditional Chinese Medicine, Guiyang, 550002, China.;2First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550001, China;3Guizhou TCM Inheritance and Innovation Team on Oncology, Guiyang, 550001;4Guihang Guiyang Hospital, Guiyang, 550025, China.

    The combination of Chinese patent medicine Astragalus injection and Western medicine has achieved a certain clinical effect in colorectal cancer patients. However, due to the uneven basic conditions and research indicators of these clinical trials, it is difficult to comprehensively evaluate the effect of Astragalus injection in the adjuvant treatment of colorectal cancer. This study aimed to systematically evaluate the efficacy and safety of Astragalus injection as an adjuvant treatment for colorectal cancer.The Cochrane Library, VIP database, Wanfang database, and Chinese Academic Journal Full Text database were searched for potentially eligible articles from inception to December 15, 2018. Randomized controlled trials in which patients were diagnosed with colorectal cancer were included. Patients in the control group received chemotherapy alone or combined with other drugs, or chemotherapy combined with radiotherapy. Patients in the experimental group were treated with Astragalus injection combined with interventions in the control group.A total of 8 articles were included. Compared with Western medicine alone, the Astragalus injection could improve the therapeutic effect (RR = 1.18, 95% CI (1.01, 1.38),= 0.03), improved the quality of life of colorectal cancer patients (SMD = 1.18, 95% CI (0.86, 1.50),<0.001), inhibited leukopenia (RR = 0.55, 95% CI (0.42, 0.71),< 0.001), reduced neurotoxicity (RR = 0.43, 95% CI (0.34, 0.56),< 0.001), and reduced the incidence of nausea and vomiting (RR = 0.67, 95% CI (0.55, 0.80),< 0.001).Astragalus injection can reduce the toxicity and improve the efficiency of the conventional Western medicine in the treatment of colorectal cancer.

    Astragalus injection, Colorectal cancer, Adjuvant therapy, Meta-analysis, Randomized controlled trial

    As an adjuvant treatment of colorectal cancer, a Chinese patent medicine Astragalus injection can reduce the toxicity and improve the efficiency of the conventional Western medicine.

    The herb Huang Qi ((Fisch.) Bge.) was first recorded in the the classical ancient Chinese medicine book entitled(Shennong’s Classic of Materia Medica) (Three Kingdoms period of China, 25 C.E.–220 C.E.). Huang Qi ((Fisch.) Bge.) was considered as one of the representative herb with the function of tonifying the Qi (one of the vital energies in the traditional Chinese medicine theory that circulates around the body at all times). Pharmarcology studies have found that Huang Qi ((Fisch.) Bge.) plays an anti-cancer role by regulating immunity, inducing apoptosis of tumor cells, and inhibiting the growth and metastasis of tumor cells. Astragalus injection, a Chinese patent medicine approved by the State Food and Drug Administration of China with the serial number of 2001ZFB0171, contains Huang Qi ((Fisch.) Bge.) and other ingredients that are widely used in clinical practice of cancer treatment.

    Background

    Colorectal cancer is the third most common cancer in the world and the fourth leading cause of death from malignant tumors[1]. A report in 2015 showed an increase in the incidence and mortality rates of colorectal cancer in China [2]. Surgery is the main treatment for colorectal cancer, while radiotherapy and chemotherapy can reduce the incidence of recurrence and metastasis. Moreover, studies have shown that the 5-year overall survival rate of colorectal cancer is 90%. Local recurrence occurs in 5% to 10% of patients after operation. The overall survival rate of patients with metastatic or recurrent colorectal cancer is reduced to 5% [3, 4]. Therefore, it is necessary for patients with colorectal cancer to undergo radiotherapy and chemotherapy after operation. However, the side effects caused by radiotherapy and chemotherapy often deter patients. Traditional Chinese medicine can reduce their adverse reactions and increase the therapeutic effect, thus prolonging the survival rate of colorectal cancer patients [5]. Studies have shown that most patients receiving chemotherapy develop gastrointestinal toxicity and myelosuppression, including diarrhea, mucositis, nausea, vomiting, neutropenia, and febrile neutropenia [6]. Irinotecan and capecitabine combined with radiotherapy for locally advanced rectal cancer, 11 cases of leukopenia, 10 cases of neutropenia, and 12 cases of diarrhea were observed in 20 patients [7]. On the other hand, 5-fluorouracil is a chemotherapeutic drug that is widely used in colorectal cancer, may have adverse reactions including alopecia and leukopenia [8]. The standard chemotherapy regimen for stage III colon cancer is oxaliplatin, with the most common side effects of neutropenia, peripheral neuropathy, vomiting, and diarrhea [9]. Oxaliplatin-induced neurotoxicity is the single major dose limiting factor in the treatment of colorectal cancer, which can lead to peripheral neuropathy, difficulty walking, stinging and numbness in the limbs, and increased pain [10]. The side effects of radiotherapy and chemotherapy affect the health, quality of life, and treatment of patients, thus it is necessary to choose effective drugs.

    The herb Huang Qi ((Fisch.) Bge.) was first recorded in the the classical ancient Chinese medicine book entitled(Shennong’s Classic of Materia Medica) (25 C.E.–220 C.E.), which is the earliest extant work on traditional herbs and was written in the Three Kingdoms period of China (220 C.E.–280 C.E.). Huang Qi ((Fisch.) Bge.) was considered as one of the representative herb with the function of tonifying the Qi (one of the vital energies in the traditional Chinese medicine theory that circulates around the body at all times) [11]. Astragalus injection, a Chinese patent medicine approved by the State Food and Drug Administration of China with the serial number of 2001ZFB0171, contains Huang Qi ((Fisch.) Bge.) and other ingredients that are widely used in clinical practice. In addition, Huang Qi ((Fisch.) Bge.) plays an anti-cancer role by regulating immunity, inducing apoptosis of tumor cells, and inhibiting the growth and metastasis of tumor cells [12]. According to the existing evidence, in the course of clinical treatment, colorectal cancer patients have achieved certain clinical efficacy by using Astragalus injection on the basis of Western medicine. However, due to the uneven basic conditions and research indicators of these clinical trials and the inconsistency of radiotherapy and chemotherapy schemes, it is difficult to comprehensively evaluate the effect of Astragalus injection as an adjuvant treatment for colorectal cancer. Therefore, this study aimed to systematically evaluate the efficacy and safety of Astragalus injection as an adjuvant treatment for colorectal cancer.

    Materials and methods

    Search strategy

    The Cochrane Library, VIP database, Wanfang database, and Chinese Academic Journal Full Text database were searched for potentially eligible articles from inception to December 15, 2018. The following search keywords were used: (Astragalus injection OR(Fisch.) Bge. injection OR Huang Qi injection OR Astragalus) AND (rectal cancer OR colon cancer OR intestinal cancer OR colorectal cancer). Only studies in Chinese and English language were included. Further, the authors hand-searched the reference lists to look for relevant literatures.

    Inclusion criteria

    (i) Randomized controlled trial;

    (ii) Colorectal cancer patients based on pathological/cytological diagnosis (adenocarcinoma, etc.) [13],no contraindication of chemotherapy, no obvious abnormality of liver and kidney function before treatment;

    (iii) Interventions: patients in the control group received chemotherapy alone or combined with other drugs, or chemotherapy combined with radiotherapy. Patients in the experimental group were treated with Astragalus injection combined with interventions in the control group. Chemotherapies in the 2 groups were consistent.

    (iv) Outcomes: the primary outcomes were effective rate (complete remission and partial remission according to the WHO criteria for evaluating the efficacy of solid tumors) and the Karnofsky Performance Status (KPS) score [14]. The secondary outcomes were adverse reactions, including bone marrow suppression, nausea and vomiting, and neurotoxicity.

    Outcome measurement indexes

    Effectiveness. The tumor response probability was calculated as the number of patients experiencing any response (complete response plus partial response) divided by the total number of patients in each treatment group (complete response plus partial response plus no change plus progressive disease).

    KPS score. The KPS score is a scale for assessing physical condition with a range from zero to 100 points. The higher the score, the better the health is.

    Adverse reactions. Bone marrow suppression (decreased white blood cell and platelet counts), digestive tract reaction, and neurotoxicity. The evaluation of the WHO criteria for acute and subacute toxicity of anticancer drugs is divided into 0–IV grades [15]. The proportion of adverse reactions is equal to the total number of patients with any adverse reactions (I + II + III + IV) divided by the total number of patients in each treatment group (0 + I + II + III + IV).

    Literature screening and data extraction

    All eligible articles were imported into the NoteExpress document management software for the first time, and the 2 researchers screened the records and extracted data, respectively. Any differences in this process were resolved through discussion or consultation with the third reviewer. The information included the following: name of the first author, year of publication, sample size, interventions, and outcomes.

    Assessment of the quality of the included trials

    According to the Cochrane Handbook for Systematic Reviews of Interventions Manual 5.1.0, the 2 researchers independently assessed the risk of bias for all involved records. Seven items recommended by the Cochrane manual were as follows: generation of random sequence, assignment concealment, double blindness of implementer and participant, blindness in outcome evaluation, incomplete outcome data, selective outcome report, and other bias sources.

    Statistical analysis

    The RevMan 5.3 software was used for statistical analysis. The continuous variables were represented by the standardized mean difference (SMD) and 95% confidence interval (CI) and the binary variables were represented by risk ratio (RR) and 95% CI. The statistical heterogeneity across the studies was evaluated using a chi-square test.> 0.1 and I2< 50% indicated that the heterogeneity was negligible across the studies and a meta-analysis was conducted with the fixed-effect model. On the other hand,< 0.1 or I2> 50% indicated that the heterogeneity was serious across the studies, and a meta-analysis was conducted with the random-effect model. In addition, a qualitative analysis of publication bias was conducted using funnel diagrams provided by RevMan 5.3 software.

    Results

    Publication selection

    A total of 72 related articles were retrieved, and reduplicated papers were deleted. After reading the title and abstract, 18 articles that did not meet the criteria were excluded. After reading the full texts, 12 articles were excluded, and eight articles that met the inclusion criteria were finally excluded (Figure 1).

    Basic characteristics of inclusion studies

    A total of 8 articles were included, including 583 patients: 292 in the experimental group and 291 in the control group. The basic information includes the author's name, the year of publication, the number of research samples, the age of patients, the intervention measures, and the judgment criteria. Four articles were treated with FOLFOX regimen, 1 article was treated with FOLFOX/XELOX regimen, 1 with the retitraxel+oxaliplatin regimen, and 2 with neoadjuvant chemotherapy. The criteria included at least the effectiveness, KPS score, and adverse reactions: leukopenia and thrombocytopenia, nausea and vomiting, and neurotoxicity (Table 1).

    Bias risk assessment results of the included studies

    The quality of the literature included in this study was acceptable (Figure 2).

    Clinical efficacy analysis

    Effectiveness. Five studies, with a total sample size of 383, reported efficiency [16–20]. Heterogeneity test (= 0.84, I2= 0%) supported the direct synthesis of efficiency. Therefore, fixed-effect model combined effect analysis. Meta-analysis showed that Astragalus injection combined with chemotherapy could improve the treatment efficiency of colorectal cancer patients compared with chemotherapy alone. There was a significant difference between the 2 groups (RR=1.18,95%CI(1.01, 1.38),=0.03)(Figure 3).

    Improvement of quality of life. A total of 3 studies reported improvement of KPS [20–22]. Ninety cases in the experimental group and 90 cases in the control group were tested for heterogeneity (= 0.33, I2= 11%) using the fixed-effect model. Meta-analysis showed that Astragalus injection combined with chemotherapysignificantlyimprovedthequalityof life of colorectal cancer patients compared with chemotherapy alone. There were significant differences between the 2 groups(SMD= 1.18, 95% CI (0.86, 1.50),< 0.001) (figure 4).

    Figure 1 Document retrieval process

    Adverse reactions

    Platelet counts. Four studies, with a sample size of 323, reported changes in platelet count before and after treatment [16–18, 20] using the heterogeneity test (= 0.90, I2= 0%). Therefore, fixed-effect model analysis was used, but the statistical results showed no significant difference (RR = 0.74, 95% CI (0.55, 1.01),= 0.06), likely associated with too few studies included (figure 5).

    Leukocyte counts. Six studies reported leukopenia [16–20, 23] with 232 cases in the experimental group, 231 cases in the control group and heterogeneity test (= 0.42, I2= 0%). The results showed that Astragalus injection could inhibit the adverse reaction of leukopenia (RR = 0.55, 95% CI (0.42, 0.71),< 0.001), through fixed-effect model analysis (Figure 5).

    Neurotoxicity. Five studies reported neurotoxicity [18–22] with 333 samples and heterogeneity test (= 0.95, I2= 0%). Consequently, using the fixed-effect model analysis, the results showed that the adjuvant treatment of Astragalus injection could reduce the adverse reactions of neurotoxicity (RR = 0.43, 95% CI (0.34, 0.56),< 0.001) (figure 5).

    Nausea and vomiting. Six studies reported nausea and vomiting [16–20, 22] with a sample size of 443 cases and heterogeneity test (= 0.82, I2= 0%), therefore, using the fixed effect model analysis, the results showed that the adjuvant treatment of Astragalus injection can reduce the adverse reactions of nausea and vomiting (RR = 0.67, 95% CI (0.55, 0.80),< 0.001) (figure 5).

    Discussion

    Radiotherapy and chemotherapy, as the main treatment of malignant tumors, play a significant role in inhibiting the development of tumors, controlling the recurrence and metastasis of tumors as well as consolidating curative effect and improving survival rate. However, due to its non-recognition of the normal and pathological tissues of the human body, cancer patients cannot tolerate serious toxic and side effects after receiving chemotherapy. Such adverse reactions have serious adverse effects on the quality of life of patients with malignant tumors. In addition, patients with malignant tumors are in critical conditions and have a long disease course. Tumor consumptionleadstothedecline ofimmunityand unfavorable physical changes of patients. Therefore, the incidence and severity of adverse reactions of radiotherapy and chemotherapy have increased. It may even lead some patients to treatment termination because of intolerance, which seriously affects the therapeutic effect of patients with malignant tumors. Hence, it is necessary to take effective measures to improve efficiency and reduce toxicity.

    Table 1 Basic features of the study

    T, experimental group; C, control group; NA, not mentioned; HQ, Astragalus injection; FOLFOX, oxaliplatin + calcium folinate +5-fluorouracil; XELOX, oxaliplatin + capecitabine; ①, white blood cell count; ②, efficiency; ③, platelet count; ④, nausea and vomiting; ⑤, neurotoxicity; ⑥, Karnofsky Performance Status score improvement.

    Figure 2 Risk of bias graph

    Figure 3 Meta-analysis of clinical efficacy in the two groups. CI, confidence interval.

    Figure 4 Meta-analysis of KPS improvement in the two groups. CI, confidence interval.

    This study find that Astragalus injection combined with chemotherapy can improve the efficiency of the conventional Western medicine in colorectal cancer patients, indicating that it can play a synergistic role in the treatment of colorectal cancer. The KPS score assesses the patient's health status according to the patient's condition, self-care level, and whether normal exercise products are available. The KPS score increase indicates the improvement of patients' quality of life, which is helpful to reduce patients' pain and improve the clinical cure rate. Through meta-analysis of the safety and efficacy of Astragalus injection in the adjuvant treatment of colorectal cancer, the results show that it can improve the KPS score of colorectal cancer patients. Astragalus injection can not only improve the quality of life of patients and play a synergistic role; however, it can also reduce the side effects of bone marrow suppression. A meta-analysis of hemogram shows that Astragalus injection assisted treatment of colorectal cancer can inhibit the decline of white blood cells and alleviate bone marrow suppression and can further reduce the occurrence of adverse reactions such as digestive tract reaction and neurotoxicity, thereby improving the prognosis of patients. Therefore, the adjuvant treatment of Astragalus injection for colorectal cancer is of great significance to reduce the adverse reactions of patients.

    This study is consistent with the current research of Astragalus injection in the field of oncology. For instance, a study has shown that Astragalus can reduce nausea and vomiting caused by oxaliplatin in the treatment of colorectal cancer [24]. Astragalus injection combined with Shengmai injection can effectively reduce the bone marrow suppression level caused by radiotherapy and chemotherapy, and improve the physical condition and the quality of life of patients [25]. Astragalus injection is effective in preventing and treating neurotoxicity caused by oxaliplatin chemotherapy, which can reduce the overall incidence and severity of neurotoxicity [26]. Furthermore, studies have shown that Astragalus injection regulates the development of colon cancer by controlling the expression of calmodulin-mediated glucose regulatory proteins [27]. Lastly, the Astragalus polysaccharide inhibits 5-fluorouracil-induced cardiomyocyte apoptosis mainly by relieving oxidative stress [28].

    Conclusion

    In conclusion, Astragalus injection can play a synergistic and attenuating role in the adjuvant treatment of colorectal cancer, thereby providing a clinicalmedicationreference;however,larger samples and more high-quality studies are needed to further confirm the efficacy. In addition, we can do further research on the therapeutic effect of Astragalus injection on colorectal cancer patients in the future.

    Figure 5 Meta-analysis of adverse reactions. CI, confidence interval.

    1. Ahmed S, Johnson K, Ahmed O, et al. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 2014, 29: 1031–1042.

    2. Medical and Health Care Bureau of the Health and Family Planning Commission of the People's Republic of China. Regulations for diagnosis and treatment of colorectal cancer (2015 edition). Chin J Pract Surg 2015, 53: 881–894. (Chinese)

    3. van der Meij W, Rombouts AJM, Rütten H, et al. Treatment of locally recurrent rectal carcinoma in previously (chemo) irradiated patients: a review. Dis Colon Rectum 2016, 59: 148–156.

    4. Van Cutsem E, Cervantes A, Nordlinger B, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014, 3: iii1–9.

    5. Takegawa Y, Ikushima H, Ozaki K, et al. Can Kampo therapy prolong the life of cancer patients? J Med Invest 2008, 55: 99–105.

    6. Yusof MM, Abdullah NM, Sharial MM, et al. Safety and management of toxicity related to aflibercept in combination with fluorouracil, leucovorin and irinotecan in malaysian patients with metastatic colorectal cancer. Asian Pac J Cancer Prev 2016, 17: 973–978.

    7. Guan Y, Shen Y, Xu Y, et al. An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype. Therap Adv Gastroenterol 2019, 12: 1756284819852293.

    8. Lim H, Kim SY, Lee E, et al. Sex-dependent adverse drug reactions to 5-fluorouracil in colorectal cancer. Biol Pharm Bull 2019, 42: 594–600.

    9. Pissarra A, Malheiro M, Matos LV, et al. Severe rhabdomyolysis related to oxaliplatin adjuvant therapy for colorectal cancer. BMJ Case Rep 2019, 12: e228673.

    10. Banach M, Zygulska AL, Krzemieniecki K. Oxaliplatin treatment and peripheral nerve damage in cancer patients: A Polish cohort study. J Cancer Res Ther 2018, 14: 1010–1013.

    11. Yin J, Guo LG. Modern Research and Clinical Application of Traditional Chinese Medicine I. Xueyuan Publishing House, 1993. (Chinses)

    12. Liu Y. Antineoplastic mechanism and research progress of Astragalus membranaceus. Cardiov Dis J Integr Tradit Chin West Med 2018, 6: 42–43. (Chinese)

    13. Gu J, Wang JP. Chinese colorectal cancer diagnosis and treatment standard (2017 edition). Chin J Pract Surg, 2018, 38: 1089–1103. (Chinese)

    14. Arias de la Vega F, Domínguez Domínguez MA, Manterola Burgaleta A, et al. Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinom as. Prelim inary results of a phaseⅡ, single-institutional trial. Clin Transl Oncol 2005, 7: 60–65.

    15. Sun Y, Zhou JC. Handbook of Internal Medicine of Clinical Oncology (4th edition). Beijing: People's Health Press, 2003. (Chinese)

    16. Yang Z, Rao SL, Qi SR, et al. Attenuation effect of Astragalus injection on neoadjuvant chemotherapy combined with three-dimensional conformal intensity-modulated radiotherapy for colorectal cancer. J N Chin Med, 2018, 50: 171–173. (Chinese)

    17. Zhou HB, Cui JH, Shi CJ, et al. Clinical observation of Huangqi injection combined with neoadjuvant chemotherapy and three-dimensional conformal radiotherapy for colorectal cancer. China Pharm 2017, 28: 3688–3691. (Chinese)

    18. Chen Y, Wang YF. Astragalus injection assisted raltitrexed combined with oxaliplatin in the treatment of advanced colorectal cancer. Chin J N Drugs Clin Remedies 2014, 33: 218–221. (Chinese)

    19. Wei JN, Liu JB, Yang ZJ, et al. Clinical observation of Huangqi injection combined with FOLFOX4 regimen in the treatment of advanced colorectal cancer. China Medical Association Sub-health Branch Election Conference and "Treatment of Diseases" and Sub-health Prevention Forum, 2012. (Chinese)

    20. Chen F. Effect of Astragalus injection combined with chemotherapy on quality of life in postoperative patients with advanced colorectal cancer. Hebei J Tradit Chin Med 2009, 31: 1696–1698. (Chinese)

    21. Luo M, Feng JP, Bu JJ, et al. Therapeutic effect of Huangqi injection on neurotoxicity induced by oxaliplatin. Hubei Univ Chin Med 2012, 14: 49–50. (Chinese)

    22. Zhu YM. Clinical study on the treatment of chemotherapy-related toxic and side effects of colorectal cancer by selective drug use of traditional Chinese medicine. Hubei University of Traditional Chinese Medicine, 2012. (Chinese)

    23. Gao YS, Li Y, Fu FN. Observation on the effect of Astragalus injection in preventing leukopenia before neoadjuvant chemotherapy for colorectal cancer. Chin J Coloproctol 2018, 38: 17–19. (Chinese)

    24. Chen MH, May H, Zhou IW, et al. Integrative medicine for relief of nausea and vomiting in the treatment of colorectal cancer using oxaliplatin-based chemotherapy: a systematic review and meta-analysis. Phytother Res 2016, 30: 741–753.

    25. Jiang YL. Clinical study of Huangqi injection combined with Shengmai injection in treating leukopenia after chemotherapy and chemotherapy. Asia-Pacific Tradit Med 2016, 12: 148–149. (Chinese)

    26. Chen Y, Huang HX. The effect of Astragalus injection combined with Mi Ke Bao on prevention and treatment of neurotoxicity caused by oxaliplatin chemotherapy. J Mod Oncol 2018, 26: 1259–1262. (Chinese)

    27. Wang Y, Auyeung KK, Zhang X, et al. Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regula-regulated protein expression. BMC Complement Altern Med 2014, 14: 401.

    28. Wu DZ, Liu W, Li SB, et al. Intervention of Astragalus polysaccharide on myocardial injury induced by 5-fluorouracil. Chin J Lab Diagn 2018, 22: 1995–1998. (Chinese)

    :

    This work was supported by a grant from the National Natural Science Foundation of China Regional Science Fund Project (81673862, 81660833, 81760814), Guizhou Provincial Department of Education Project (Qian Jiao Yan He GZS ZI (2016) 08), Guizhou Postgraduate Workstation Program (Educational Hall) Project (Qian Jiao Yan He JYSZ ZI (2014) 018), Guizhou Science and Technology Department Project (Qian Ke he Ren Cai (2016) 4032) and Guizhou Provincial Organization Department Project (Qian Ren Ban Fa (2018) No.3).

    :

    KPS, Karnofsky Performance Status; SMD, standardized mean difference; CI, confidence interval; RR, risk ratio;

    :

    The authors declare that they have no conflict of interest. The authors alone are responsible for the content of the paper.

    :

    Jia Wang, Zhu Yang, Fengxi Long, et al. Astragalus injection as an adjuvant treatment for colorectal cancer: a meta-analysis. Traditional Medicine Research 2020, 5 (1): 53–61.

    : Xiaohong Sheng

    : 8 December 2019,

    27 Decembe 2019,

    :30 December 2019.

    Dongxin Tang. First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No.71 Baoshan North Road, Yunyan District, Guiyang, 550001, China. E-mail: tangdongxin@sina.com.

    亚洲精品影视一区二区三区av| 久久久久久九九精品二区国产| 嫩草影院入口| 嫩草影院精品99| 欧美xxxx黑人xx丫x性爽| 99在线视频只有这里精品首页| 精品人妻熟女av久视频| 欧美色视频一区免费| 久99久视频精品免费| 精品久久久久久成人av| 伦精品一区二区三区| 国产伦一二天堂av在线观看| 成年版毛片免费区| 婷婷精品国产亚洲av在线| 亚洲一级一片aⅴ在线观看| 午夜亚洲福利在线播放| 午夜激情欧美在线| 欧美最黄视频在线播放免费| 99视频精品全部免费 在线| 亚洲av中文av极速乱| 菩萨蛮人人尽说江南好唐韦庄 | 97超碰精品成人国产| 精品不卡国产一区二区三区| 精华霜和精华液先用哪个| 久久精品国产清高在天天线| 亚洲欧美精品自产自拍| 激情 狠狠 欧美| 中国国产av一级| 日本成人三级电影网站| 村上凉子中文字幕在线| 噜噜噜噜噜久久久久久91| 给我免费播放毛片高清在线观看| 日韩欧美国产在线观看| 免费看光身美女| 国产三级中文精品| 久久精品综合一区二区三区| av国产免费在线观看| av在线观看视频网站免费| 亚洲性久久影院| 亚洲欧美精品自产自拍| 日本精品一区二区三区蜜桃| 亚洲欧美清纯卡通| 成年av动漫网址| av在线亚洲专区| 国产三级中文精品| 我要看日韩黄色一级片| 久久精品国产亚洲网站| 久久久欧美国产精品| 老熟妇仑乱视频hdxx| 国产精品一及| 午夜免费激情av| 亚洲人成网站在线播| 尾随美女入室| 亚洲精品日韩在线中文字幕 | 一个人免费在线观看电影| 国产精品美女特级片免费视频播放器| 一级毛片aaaaaa免费看小| 在线观看免费视频日本深夜| 久久精品国产清高在天天线| 久久九九热精品免费| 久久久久久久久久久丰满| 亚洲最大成人中文| 最新中文字幕久久久久| 亚洲欧美日韩卡通动漫| 国产91av在线免费观看| 人人妻人人澡人人爽人人夜夜 | 99热全是精品| 欧美日本视频| 国产精品无大码| 亚洲无线在线观看| 美女高潮的动态| 国产亚洲精品综合一区在线观看| 99国产极品粉嫩在线观看| 久久精品影院6| 久久久久九九精品影院| 久久久久久久亚洲中文字幕| 麻豆久久精品国产亚洲av| 亚洲av.av天堂| 毛片一级片免费看久久久久| 老女人水多毛片| 国产高清不卡午夜福利| 你懂的网址亚洲精品在线观看 | 国产中年淑女户外野战色| 亚洲av成人av| 1000部很黄的大片| 欧美日韩综合久久久久久| 日韩欧美在线乱码| 国产精品一二三区在线看| 两个人的视频大全免费| 九九爱精品视频在线观看| 精品无人区乱码1区二区| 午夜视频国产福利| 国产三级在线视频| 日本a在线网址| 男人狂女人下面高潮的视频| 亚洲av五月六月丁香网| 国产私拍福利视频在线观看| 中出人妻视频一区二区| 亚洲av成人精品一区久久| 九九在线视频观看精品| 亚洲av成人av| 日本黄色片子视频| 色综合色国产| 国产成人91sexporn| 亚洲婷婷狠狠爱综合网| 青春草视频在线免费观看| 三级国产精品欧美在线观看| a级毛片免费高清观看在线播放| 久99久视频精品免费| 赤兔流量卡办理| 亚洲av中文av极速乱| 黄色视频,在线免费观看| 在线看三级毛片| 欧美日韩国产亚洲二区| 日韩精品青青久久久久久| 成人特级av手机在线观看| 热99re8久久精品国产| 亚洲人成网站在线观看播放| 少妇人妻一区二区三区视频| 18禁在线无遮挡免费观看视频 | 91麻豆精品激情在线观看国产| 在线观看午夜福利视频| 日韩大尺度精品在线看网址| 神马国产精品三级电影在线观看| 69人妻影院| 高清毛片免费看| 变态另类成人亚洲欧美熟女| АⅤ资源中文在线天堂| 麻豆av噜噜一区二区三区| 欧美+日韩+精品| 亚洲精品日韩av片在线观看| videossex国产| 亚洲不卡免费看| 国产亚洲精品久久久久久毛片| 亚洲国产欧洲综合997久久,| 给我免费播放毛片高清在线观看| 91麻豆精品激情在线观看国产| 美女 人体艺术 gogo| 日日撸夜夜添| 老熟妇仑乱视频hdxx| 99久久久亚洲精品蜜臀av| 全区人妻精品视频| 精品一区二区免费观看| 给我免费播放毛片高清在线观看| 尾随美女入室| av免费在线看不卡| 午夜激情福利司机影院| 国产中年淑女户外野战色| 免费搜索国产男女视频| 成人一区二区视频在线观看| 一本一本综合久久| 深爱激情五月婷婷| 狠狠狠狠99中文字幕| 超碰av人人做人人爽久久| 最近中文字幕高清免费大全6| av在线播放精品| 99热这里只有精品一区| 三级国产精品欧美在线观看| а√天堂www在线а√下载| 又爽又黄无遮挡网站| 亚洲欧美日韩东京热| 3wmmmm亚洲av在线观看| 久久久色成人| 免费看光身美女| 我的女老师完整版在线观看| 一级黄片播放器| 一个人看视频在线观看www免费| 一区福利在线观看| 成人性生交大片免费视频hd| 久久鲁丝午夜福利片| 精品一区二区免费观看| 麻豆精品久久久久久蜜桃| 日本熟妇午夜| 最新中文字幕久久久久| 久久精品影院6| 国产一区二区亚洲精品在线观看| 亚洲在线自拍视频| 欧美高清成人免费视频www| av在线亚洲专区| 全区人妻精品视频| 在线观看一区二区三区| 国产亚洲91精品色在线| a级毛片a级免费在线| 精品一区二区免费观看| 18禁黄网站禁片免费观看直播| 最好的美女福利视频网| 精品人妻偷拍中文字幕| 中文字幕av成人在线电影| 99久久精品热视频| 亚洲aⅴ乱码一区二区在线播放| 久久久国产成人免费| 晚上一个人看的免费电影| 国产伦一二天堂av在线观看| 日日啪夜夜撸| 22中文网久久字幕| 在线观看av片永久免费下载| 成人三级黄色视频| 亚洲性夜色夜夜综合| av女优亚洲男人天堂| 精品久久久久久久久久免费视频| 日韩精品青青久久久久久| 一个人观看的视频www高清免费观看| 人妻丰满熟妇av一区二区三区| 欧美日本亚洲视频在线播放| 亚洲av免费高清在线观看| 熟妇人妻久久中文字幕3abv| 国产成年人精品一区二区| av女优亚洲男人天堂| 国产精品伦人一区二区| 国产蜜桃级精品一区二区三区| 久久国产乱子免费精品| 亚洲乱码一区二区免费版| 高清日韩中文字幕在线| 91久久精品国产一区二区成人| 51国产日韩欧美| 十八禁国产超污无遮挡网站| 国产成人一区二区在线| 亚洲专区国产一区二区| 99热网站在线观看| 麻豆乱淫一区二区| 12—13女人毛片做爰片一| 色播亚洲综合网| 精品久久久久久久人妻蜜臀av| 国产伦精品一区二区三区视频9| 51国产日韩欧美| 在线a可以看的网站| 九九热线精品视视频播放| 国产精品久久电影中文字幕| 国产一区二区三区av在线 | a级毛色黄片| 亚洲电影在线观看av| 免费大片18禁| a级一级毛片免费在线观看| 久久久成人免费电影| aaaaa片日本免费| 中文亚洲av片在线观看爽| 成人漫画全彩无遮挡| 最近最新中文字幕大全电影3| 少妇人妻一区二区三区视频| 一级黄片播放器| 熟女电影av网| 亚洲高清免费不卡视频| 99热这里只有是精品50| 国产精品av视频在线免费观看| 国产人妻一区二区三区在| 久久久久国产网址| 日韩强制内射视频| 亚洲人成网站高清观看| 久久婷婷人人爽人人干人人爱| 欧美色欧美亚洲另类二区| 国产亚洲精品久久久久久毛片| 午夜亚洲福利在线播放| 乱码一卡2卡4卡精品| 亚洲精品一区av在线观看| 少妇猛男粗大的猛烈进出视频 | 日产精品乱码卡一卡2卡三| 一个人观看的视频www高清免费观看| 午夜日韩欧美国产| 国产一区二区亚洲精品在线观看| 午夜精品一区二区三区免费看| 亚洲成人精品中文字幕电影| 色噜噜av男人的天堂激情| 天堂av国产一区二区熟女人妻| 大香蕉久久网| 亚洲电影在线观看av| 91麻豆精品激情在线观看国产| 天天躁日日操中文字幕| 精品99又大又爽又粗少妇毛片| 日韩欧美在线乱码| 亚洲精品粉嫩美女一区| 黄色欧美视频在线观看| 国产伦精品一区二区三区视频9| 色视频www国产| 身体一侧抽搐| 日韩高清综合在线| 可以在线观看毛片的网站| 熟女电影av网| 99精品在免费线老司机午夜| 日本黄色片子视频| 欧美一级a爱片免费观看看| 精品一区二区三区视频在线观看免费| 免费不卡的大黄色大毛片视频在线观看 | av在线观看视频网站免费| 禁无遮挡网站| 你懂的网址亚洲精品在线观看 | 超碰av人人做人人爽久久| 一级毛片aaaaaa免费看小| 亚洲av.av天堂| 亚洲av电影不卡..在线观看| 国产精品无大码| 国产麻豆成人av免费视频| 亚洲经典国产精华液单| 日本爱情动作片www.在线观看 | 色播亚洲综合网| 色5月婷婷丁香| 久久久久久国产a免费观看| 中文在线观看免费www的网站| 一a级毛片在线观看| 麻豆乱淫一区二区| 午夜福利在线在线| 能在线免费观看的黄片| 我的老师免费观看完整版| 精品久久久久久久末码| 色综合色国产| 男女视频在线观看网站免费| 久久久久国产网址| 久久6这里有精品| 精品久久久久久久人妻蜜臀av| 自拍偷自拍亚洲精品老妇| 国产免费一级a男人的天堂| 日日摸夜夜添夜夜添小说| 日日摸夜夜添夜夜添小说| 你懂的网址亚洲精品在线观看 | 亚洲av免费高清在线观看| 亚洲在线自拍视频| 亚洲电影在线观看av| 在线免费观看的www视频| 欧美3d第一页| 夜夜看夜夜爽夜夜摸| 我要看日韩黄色一级片| 亚洲精华国产精华液的使用体验 | 久久99热这里只有精品18| av视频在线观看入口| 久久久成人免费电影| 一区二区三区四区激情视频 | 日本一二三区视频观看| 国产探花在线观看一区二区| 亚洲精品日韩在线中文字幕 | 少妇猛男粗大的猛烈进出视频 | 国内揄拍国产精品人妻在线| 亚洲av不卡在线观看| 日本五十路高清| 91久久精品国产一区二区成人| 精品日产1卡2卡| 俺也久久电影网| 晚上一个人看的免费电影| 白带黄色成豆腐渣| 长腿黑丝高跟| 成人二区视频| 欧美+亚洲+日韩+国产| 欧美激情在线99| av专区在线播放| 最新中文字幕久久久久| 久久99热6这里只有精品| 日本黄色视频三级网站网址| 美女黄网站色视频| 别揉我奶头~嗯~啊~动态视频| 精品久久久久久久久久免费视频| 久久九九热精品免费| 久久精品国产鲁丝片午夜精品| 国产精品久久久久久久电影| 久久久久久国产a免费观看| 天堂网av新在线| 深夜精品福利| 日韩大尺度精品在线看网址| 国产一区二区在线av高清观看| 天堂网av新在线| 国产精品一区二区三区四区久久| 成人一区二区视频在线观看| 97在线视频观看| 真人做人爱边吃奶动态| 国产精品精品国产色婷婷| 在线播放无遮挡| 黄色视频,在线免费观看| 国产亚洲精品av在线| 丰满乱子伦码专区| 免费av观看视频| 欧美性猛交黑人性爽| 在线国产一区二区在线| 最近视频中文字幕2019在线8| 97超碰精品成人国产| 露出奶头的视频| 精品久久久久久久人妻蜜臀av| 99在线人妻在线中文字幕| 真实男女啪啪啪动态图| 亚洲内射少妇av| 99热这里只有是精品50| 亚洲自偷自拍三级| 99精品在免费线老司机午夜| a级毛片a级免费在线| 亚洲欧美成人精品一区二区| 中国国产av一级| av在线亚洲专区| 我要搜黄色片| 黄色配什么色好看| 亚洲精品久久国产高清桃花| 欧美日韩一区二区视频在线观看视频在线 | 又粗又爽又猛毛片免费看| 国产精品一区www在线观看| av.在线天堂| 国产精品嫩草影院av在线观看| 麻豆久久精品国产亚洲av| 久久久国产成人免费| 22中文网久久字幕| 麻豆av噜噜一区二区三区| 91午夜精品亚洲一区二区三区| 少妇猛男粗大的猛烈进出视频 | 日本一二三区视频观看| av在线老鸭窝| 国产视频一区二区在线看| АⅤ资源中文在线天堂| 别揉我奶头 嗯啊视频| 欧美又色又爽又黄视频| 亚洲精品久久国产高清桃花| 亚洲欧美日韩东京热| 热99在线观看视频| 一级av片app| 婷婷色综合大香蕉| 午夜精品国产一区二区电影 | 日本色播在线视频| 女人十人毛片免费观看3o分钟| 日本 av在线| 欧美xxxx黑人xx丫x性爽| 精品久久久噜噜| 91午夜精品亚洲一区二区三区| 国内精品宾馆在线| 男女啪啪激烈高潮av片| 成人性生交大片免费视频hd| 99视频精品全部免费 在线| 久久国产乱子免费精品| 美女黄网站色视频| 少妇人妻精品综合一区二区 | 中文字幕免费在线视频6| 人妻夜夜爽99麻豆av| 成人漫画全彩无遮挡| 天堂网av新在线| 成人三级黄色视频| 欧美在线一区亚洲| 成人一区二区视频在线观看| 搡女人真爽免费视频火全软件 | 日韩,欧美,国产一区二区三区 | 亚洲人成网站在线播放欧美日韩| 国产片特级美女逼逼视频| 一进一出抽搐gif免费好疼| 久久久久性生活片| 搡老岳熟女国产| 成年av动漫网址| 美女黄网站色视频| 亚洲中文日韩欧美视频| 天美传媒精品一区二区| 欧美区成人在线视频| 精品一区二区三区视频在线| 国产精品福利在线免费观看| 亚洲久久久久久中文字幕| 免费电影在线观看免费观看| 一级毛片aaaaaa免费看小| 中文字幕精品亚洲无线码一区| av在线天堂中文字幕| 老师上课跳d突然被开到最大视频| av天堂在线播放| 美女cb高潮喷水在线观看| 国内精品一区二区在线观看| 九九热线精品视视频播放| 亚洲欧美日韩高清在线视频| 99久久精品热视频| 欧美国产日韩亚洲一区| 最新中文字幕久久久久| 欧美3d第一页| 久久精品国产自在天天线| 国产aⅴ精品一区二区三区波| 十八禁网站免费在线| 国产在线男女| 欧美在线一区亚洲| 国产免费一级a男人的天堂| 日本撒尿小便嘘嘘汇集6| 男女下面进入的视频免费午夜| 又黄又爽又刺激的免费视频.| 精品久久久久久久久av| 亚洲最大成人中文| 日本欧美国产在线视频| 自拍偷自拍亚洲精品老妇| 亚洲精品乱码久久久v下载方式| 国产高清视频在线观看网站| 亚洲人成网站在线观看播放| 亚洲av熟女| 日本成人三级电影网站| 欧美xxxx性猛交bbbb| 亚洲乱码一区二区免费版| 欧美国产日韩亚洲一区| 成年女人永久免费观看视频| 黄色一级大片看看| 99久国产av精品国产电影| 国产男靠女视频免费网站| 欧美极品一区二区三区四区| 欧美精品国产亚洲| 亚洲精华国产精华液的使用体验 | 禁无遮挡网站| 12—13女人毛片做爰片一| 中文字幕精品亚洲无线码一区| 成人三级黄色视频| 99热这里只有是精品50| 我要搜黄色片| 久久久久久伊人网av| 亚洲在线自拍视频| 观看美女的网站| 看十八女毛片水多多多| 国产精品嫩草影院av在线观看| 亚洲乱码一区二区免费版| 欧美中文日本在线观看视频| 免费av毛片视频| 欧美潮喷喷水| 亚洲七黄色美女视频| 熟女电影av网| 国产精品一二三区在线看| 免费av毛片视频| 看黄色毛片网站| 毛片一级片免费看久久久久| 中文字幕av成人在线电影| 欧美极品一区二区三区四区| 变态另类丝袜制服| 天天一区二区日本电影三级| 亚洲欧美日韩高清专用| www日本黄色视频网| 国产高清三级在线| 成人漫画全彩无遮挡| 女同久久另类99精品国产91| 美女 人体艺术 gogo| 久久这里只有精品中国| 亚洲中文日韩欧美视频| 精品久久久久久久末码| 午夜福利在线在线| 午夜久久久久精精品| 我要看日韩黄色一级片| 插逼视频在线观看| 国产69精品久久久久777片| 国产成人91sexporn| 免费av观看视频| 久久久久国内视频| 国产精品久久久久久亚洲av鲁大| 在线播放国产精品三级| 乱人视频在线观看| 成人特级黄色片久久久久久久| 精品无人区乱码1区二区| 日韩欧美一区二区三区在线观看| 免费av观看视频| 成人无遮挡网站| 日产精品乱码卡一卡2卡三| 日韩欧美国产在线观看| 久久综合国产亚洲精品| 国产精品久久久久久久电影| 欧美中文日本在线观看视频| 免费高清视频大片| 日韩,欧美,国产一区二区三区 | 亚洲精品影视一区二区三区av| 男女啪啪激烈高潮av片| 精品久久久久久久久久久久久| 亚洲精品国产成人久久av| 欧美日韩综合久久久久久| 亚洲成a人片在线一区二区| www.色视频.com| 91在线观看av| 亚洲va在线va天堂va国产| 亚洲自拍偷在线| 日韩大尺度精品在线看网址| 亚洲国产精品成人综合色| 欧美一区二区精品小视频在线| 蜜桃久久精品国产亚洲av| 国产精品三级大全| 亚洲色图av天堂| 国产成人aa在线观看| 久久亚洲精品不卡| 亚洲三级黄色毛片| 黄色视频,在线免费观看| 亚洲国产精品合色在线| 美女内射精品一级片tv| 三级国产精品欧美在线观看| 成人av在线播放网站| 日韩精品青青久久久久久| 啦啦啦啦在线视频资源| 看非洲黑人一级黄片| 日本在线视频免费播放| 色吧在线观看| 久久人妻av系列| 长腿黑丝高跟| 欧美日本视频| 色播亚洲综合网| 熟女电影av网| 在现免费观看毛片| 又粗又爽又猛毛片免费看| 亚洲欧美精品综合久久99| 成年女人永久免费观看视频| 日本成人三级电影网站| 干丝袜人妻中文字幕| 变态另类丝袜制服| 变态另类成人亚洲欧美熟女| 欧美丝袜亚洲另类| 黄片wwwwww| 中文在线观看免费www的网站| 亚洲熟妇熟女久久| 亚洲最大成人手机在线| 日日摸夜夜添夜夜添av毛片| 深爱激情五月婷婷| 网址你懂的国产日韩在线| 国产亚洲av嫩草精品影院| 欧美又色又爽又黄视频| 中文字幕免费在线视频6| 99热只有精品国产| 亚洲第一电影网av| 国产伦在线观看视频一区| 日日干狠狠操夜夜爽| 人人妻人人澡人人爽人人夜夜 | 最近中文字幕高清免费大全6| 波野结衣二区三区在线| 色播亚洲综合网| 国产精品一二三区在线看| 成人三级黄色视频| 91精品国产九色| avwww免费| 国产aⅴ精品一区二区三区波| 国产一区二区激情短视频| 国产精品不卡视频一区二区| 午夜亚洲福利在线播放| 小说图片视频综合网站| 国产美女午夜福利| 久久精品国产自在天天线|